Analyte Health announced this week that it has received $22 million in financing from New World Ventures, Apex Venture Partners, and Mohr Davidow. Founded in 2007, the Chicago-based healthcare consultation network has been working to develop the next generation of personalized online healthcare information.
STDTestExpress is the first example of the kind of specialized online medical service that Analyte Health is hoping to create within its health network. In future projects, the company is aiming to further online health consultation for complex and specialized issues beyond sexual health. The company’s board of directors includes president and CEO Sridhar Murthy, co-founder Dan Malven, Lon Chow of Apex Venture Partners, and New World Ventures partner Matthew McCall. “Analyte Health is at the cutting edge, using automation to provide consumers with high quality medical support that is easier, faster, and more affordable than traditional methods,” said McCall. “We are pleased to be invested in a company which is so passionately pursuing change for the benefit of healthcare consumers.” The latest round of funding is the first venture round for the online healthcare company.
In an increasingly fragmented world economy, global alignment has become both an opportunity and a…
The world-renowned CES Innovation Awards® program is an annual competition honoring outstanding design and engineering…
intive has expanded its AI ambitions with a new enterprise partnership that designates Cursor as…
HostMilano 2025 concluded its 44th edition on October 26 and remains the premier world fair…
As the new year approaches, the Software Report—a trusted source for market research and industry…
Now that AI has been on the scene for a number of years, we can…